• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐氨基糖苷类粪肠球菌所致实验性心内膜炎中β-内酰胺酶的产生

beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis.

作者信息

Ingerman M, Pitsakis P G, Rosenberg A, Hessen M T, Abrutyn E, Murray B E, Levison M E

出版信息

J Infect Dis. 1987 Jun;155(6):1226-32. doi: 10.1093/infdis/155.6.1226.

DOI:10.1093/infdis/155.6.1226
PMID:3106510
Abstract

We used a beta-lactamase-producing (beta L+) strain of Streptococcus faecalis that also had high levels of resistance to all aminoglycosides to induce experimental endocarditis in rats. The rats were treated for five or 10 days with procaine penicillin, vancomycin, gentamicin, rifampin, or ciprofloxacin (alone or in various combinations), or with penicillin plus clavulanic acid. The levels of penicillin in serum and vegetations declined rapidly in the beta L+-infected rats treated with procaine penicillin alone, unlike the sustained levels of penicillin in either beta L- -infected rats treated with procaine penicillin or beta L+-infected rats treated with penicillin plus clavulanic acid. For the beta L+-infected rats, the enterococcal counts in vegetations were significantly reduced (greater than 3 log10 cfu/g) only by vancomycin and by penicillin plus clavulanic acid. The efficacy of the latter regimen probably resulted from the inhibition of penicillin inactivation by clavulanic acid in vegetations infected with the beta L+ strain. Our in vivo findings document the biologic significance of beta-lactamase production.

摘要

我们使用一株产β-内酰胺酶(βL+)的粪肠球菌,该菌株对所有氨基糖苷类抗生素也具有高水平耐药性,以诱导大鼠发生实验性心内膜炎。用普鲁卡因青霉素、万古霉素、庆大霉素、利福平或环丙沙星(单独使用或联合使用),或青霉素加克拉维酸对大鼠进行5天或10天的治疗。单独用普鲁卡因青霉素治疗的βL+感染大鼠血清和赘生物中的青霉素水平迅速下降,这与用普鲁卡因青霉素治疗的βL-感染大鼠或用青霉素加克拉维酸治疗的βL+感染大鼠中青霉素的持续水平不同。对于βL+感染的大鼠,仅万古霉素和青霉素加克拉维酸能使赘生物中的肠球菌计数显著降低(大于3 log10 cfu/g)。后一种治疗方案的疗效可能是由于克拉维酸抑制了感染βL+菌株的赘生物中青霉素的失活。我们的体内研究结果证明了β-内酰胺酶产生的生物学意义。

相似文献

1
beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis.耐氨基糖苷类粪肠球菌所致实验性心内膜炎中β-内酰胺酶的产生
J Infect Dis. 1987 Jun;155(6):1226-32. doi: 10.1093/infdis/155.6.1226.
2
Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.达托霉素、万古霉素和氨苄西林-庆大霉素治疗耐青霉素肠球菌所致实验性心内膜炎的比较。
Antimicrob Agents Chemother. 1992 Sep;36(9):1864-9. doi: 10.1128/AAC.36.9.1864.
3
Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.由对庆大霉素具有高水平耐药性的产β-内酰胺酶粪肠球菌菌株引起的实验性心内膜炎的治疗。
Antimicrob Agents Chemother. 1989 Jul;33(7):1019-22. doi: 10.1128/AAC.33.7.1019.
4
Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis.在肠球菌性心内膜炎中可与青霉素协同作用的氨基糖苷类药物的最低浓度。
Antimicrob Agents Chemother. 1981 Sep;20(3):405-9. doi: 10.1128/AAC.20.3.405.
5
Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.氨苄西林-舒巴坦与万古霉素治疗由产β-内酰胺酶、对庆大霉素高度耐药的粪肠球菌分离株引起的实验性心内膜炎的比较。
Antimicrob Agents Chemother. 1993 Jul;37(7):1447-51. doi: 10.1128/AAC.37.7.1447.
6
Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.替考拉宁两种给药方案对由产β-内酰胺酶且对庆大霉素高度耐药的粪肠球菌菌株引起的实验性心内膜炎的疗效。
Antimicrob Agents Chemother. 1990 May;34(5):827-30. doi: 10.1128/AAC.34.5.827.
7
Daptomycin (LY146032) treatment of experimental enterococcal endocarditis.达托霉素(LY146032)治疗实验性肠球菌心内膜炎。
Antimicrob Agents Chemother. 1988 Jun;32(6):877-81. doi: 10.1128/AAC.32.6.877.
8
[Aminoglycosides in the treatment of infectious endocarditis].[氨基糖苷类药物在感染性心内膜炎治疗中的应用]
Schweiz Med Wochenschr Suppl. 1996;76:14S-20S.
9
Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.对由产β-内酰胺酶、耐氨基糖苷类肠球菌引起的实验性心内膜炎的化学预防效果与血清抑制活性延长有关。
Antimicrob Agents Chemother. 1990 Jun;34(6):1068-74. doi: 10.1128/AAC.34.6.1068.
10
Antibiotic synergism in enterococcal endocarditis.肠球菌性心内膜炎中的抗生素协同作用。
J Lab Clin Med. 1976 Jul;88(1):132-41.

引用本文的文献

1
The Enterococcus: a Model of Adaptability to Its Environment.肠球菌:适应环境的典范。
Clin Microbiol Rev. 2019 Jan 30;32(2). doi: 10.1128/CMR.00058-18. Print 2019 Mar 20.
2
Polyclonal diffusion of beta-lactamase-producing Enterococcus faecium.产β-内酰胺酶屎肠球菌的多克隆扩散。
J Clin Microbiol. 2012 Jan;50(1):169-72. doi: 10.1128/JCM.05640-11. Epub 2011 Nov 9.
3
Emergence of vancomycin-resistant enterococci.耐万古霉素肠球菌的出现。
Emerg Infect Dis. 2001 Mar-Apr;7(2):183-7. doi: 10.3201/eid0702.010205.
4
Increasing Antimicrobial Resistance: Therapeutic Implications for Enterococcal Infections.不断增加的抗菌药物耐药性:肠球菌感染的治疗意义
Curr Infect Dis Rep. 2000 Oct;2(5):417-423. doi: 10.1007/s11908-000-0068-y.
5
Current perspectives on glycopeptide resistance.糖肽类耐药性的当前观点
Clin Microbiol Rev. 1995 Oct;8(4):585-615. doi: 10.1128/CMR.8.4.585.
6
Activity of quinolones against gram-positive cocci: clinical features.喹诺酮类药物对革兰氏阳性球菌的活性:临床特征
Drugs. 1995;49 Suppl 2:58-66. doi: 10.2165/00003495-199500492-00010.
7
Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.氨苄西林-舒巴坦与万古霉素治疗由产β-内酰胺酶、对庆大霉素高度耐药的粪肠球菌分离株引起的实验性心内膜炎的比较。
Antimicrob Agents Chemother. 1993 Jul;37(7):1447-51. doi: 10.1128/AAC.37.7.1447.
8
Increasing problems in the therapy of enterococcal infections.肠球菌感染治疗中日益增多的问题。
Eur J Clin Microbiol Infect Dis. 1993 Jun;12(6):409-12. doi: 10.1007/BF01967433.
9
Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.针对由耐万古霉素和耐氨苄西林的粪肠球菌引起的实验性心内膜炎的抗生素治疗。
Antimicrob Agents Chemother. 1993 Oct;37(10):2069-73. doi: 10.1128/AAC.37.10.2069.
10
Virulence of enterococci.肠球菌的毒力
Clin Microbiol Rev. 1994 Oct;7(4):462-78. doi: 10.1128/CMR.7.4.462.